切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2018, Vol. 12 ›› Issue (06) : 354 -357. doi: 10.3877/cma.j.issn.1674-0785.2018.06.008

所属专题: 文献

综述

全基因组外显子测序技术在2型糖尿病中的应用
周晓伟1, 李会芳1,()   
  1. 1. 650032 昆明医科大学第一附属医院糖尿病科
  • 收稿日期:2018-03-11 出版日期:2018-03-15
  • 通信作者: 李会芳
  • 基金资助:
    国家自然科学基金资助项目(81160104,30760087); 云南省科技厅-昆明医科大学应用基础研究联合专项(2018FE001(-043)); 云南省卫生科技计划项目(2017NS049)

Application of whole genome exon sequencing in type 2 diabetes mellitus

Xiaowei Zhou1, Huifang Li1,()   

  1. 1. Department of Diabetology, the First Affiliated Hospital of Kunming Medical University, Kunming 650032, China
  • Received:2018-03-11 Published:2018-03-15
  • Corresponding author: Huifang Li
  • About author:
    Corresponding Author: Li Huifang, Email:
引用本文:

周晓伟, 李会芳. 全基因组外显子测序技术在2型糖尿病中的应用[J/OL]. 中华临床医师杂志(电子版), 2018, 12(06): 354-357.

Xiaowei Zhou, Huifang Li. Application of whole genome exon sequencing in type 2 diabetes mellitus[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2018, 12(06): 354-357.

全基因组外显子测序技术是指利用目标序列捕获技术将基因组的全部外显子区域DNA捕获后进行高通量测序的基因组分析方法,对发现疾病相关的低频和罕见突变有较高的灵敏性。而2型糖尿病是以进行性的胰岛β细胞功能障碍和胰岛素抵抗为特征,遗传和环境共同作用所致的疾病,其中遗传因素在2型糖尿病发病中起重要作用。本文就全基因组外显子测序技术在2型糖尿病的遗传易感基因及其编码变异筛选中的应用做一综述。

Whole-genome exon sequencing technology is a genomic analysis method that uses target sequence capture technology to capture DNA from all exon regions of the genome for high-throughput sequencing, and has a high sensitivity for identifying disease-related low-frequency and rare mutations. Type 2 diabetes mellitus is characterized by progressive islet β-cell dysfunction and insulin resistance, and it is thought to be the result of a combination of genetic and environmental factors, in which genetic factors play an important role in the pathogenesis of type 2 diabetes. This article reviews the application of whole-genome exon sequencing in the screening of susceptibility genes and coding variants in type 2 diabetes mellitus.

1
Cho NH,Shaw JE,Karuranga S, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2017 and projections for 2045 [J]. Diabetes Res Clin Pract, 2018, 138: 271-281.
2
Stadler ZK,Vijai J,Thom P, et al. Genome-wide association studies of cancer predisposition [J]. Hematol Oncol Clin North Am, 2010, 24(5): 973-996.
3
张鑫, 李敏, 张学军. 全基因组外显子测序及其应用[J].遗传, 2011, 33(8):847-856.
4
Ng SB,Turner EH,Robertson PD, et al.Targeted capture and massively parallel sequencing of 12 human exomes [J]. Nature, 2009, 461(7261): 272-276
5
Ng SB,Buckingham KJ,Lee C, et al.Exome sequencing identifies the cause of a mendelian disorder [J]. Nat Genet, 2010, 42(1): 30-35.
6
Yang Y,Muzny DM,Reid JG, et al.Clinical whole-exome sequencing for the diagnosis of mendelian disorders [J]. N Engl J Med, 2013, 369(16): 1502-1511.
7
Bamshad MJ,Ng SB,Bigham AW, et al.Exome sequencing as a tool for Mendelian disease gene discovery [J]. Nat Rev Genet, 2011, 12(11): 745-755.
8
Veltman JA,Brunner HG.De novo mutations in human genetic disease [J]. Nat Rev Genet, 2012, 13(8): 565-575.
9
Gnirke A,Melnikov A,Maguire J, et al.Solution hybrid selection With ultra-long oligonucleotides for massively parallel targeted sequencing [J]. Nat Biotechnol, 2009, 27(2): 182-189.
10
Rabbani B,Mahdieh N,Hosomichi K, et al. Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders [J]. J Hum Genet, 2012, 57(10): 621-632.
11
饶书权, 杜廷福, 许琪. 外显子组测序在人类疾病中的应用[J]. 遗传, 2014, 36(11):1077-1086.
12
Clark MJ,Chen R,Lam HY, et al.Performance comparison of exome DNA sequencing technologies [J]. Nat Biotechnol, 2011, 29(10): 904-914.
13
Uwe S,Andreas G,Marius F, et al.De novo 454 sequencing of barcoded BAC pools for comprehensive gene survey and genome analysis in the complex genome of barley [J]. BMC Genomics, 2009, 10(1): 547.
14
Wheeler DA,Srinivasan M,Egholin M, et al. The complete genome of an individual by massively parallel DNA sequencing [J]. Nature, 2008, 452(7189): 872-876.
15
Mardis ER. Next-generation DNA sequencing methods [J]. Annu Rev Genomics Hum Genet, 2007, 9(1): 387-402.
16
罗东凤, 王少元. 全基因组外显子测序及其在遗传病研究中的应用[J]. 国际遗传学杂志, 2012, 35(3): 173-177.
17
赵蓓, 陈学军, 周夕湲, 等. 应用全外显子测序技术查找有汗性外胚叶发育不良综合征家系致病基因[J].中国皮肤性病学杂志, 2017, 31(9): 956-960.
18
Botstein D,Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease [J]. Nat Genet, 2003, 33(3): 228-237.
19
Mcclellan JM,Susser E,King MC. Schizophrenia: a common disease caused by multiple rare alleles. [J]. Br J Psychiatry, 2007, 190(3): 194-199.
20
Mcclellan J,King MC. Genetic heterogeneity in human disease [J]. Cell, 2010, 141(2): 210-217.
21
Holm H,Gudbjartsson DF,Sulem P, et al. A rare variant in MAYH6 is associated with high risk of sick sinus synodrome [J]. Nat Genet, 2011, 43(4): 316.
22
Li Y,Vinckenbosch N,Tian G, et al. Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants [J]. Nat genet, 2010, 42(11): 969-972.
23
Albrechtsen A,Grarup N,Li Y, et al. Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes [J]. Diabetologia, 2013, 56(2): 298-310.
24
Estrada K,Aukrust Ⅰ,Bjørkhaug L, et al. Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population [J]. Jama, 2014, 311(22): 2305-2314.
25
Fuchsberger C,Flannick J,Teslovich TM, et al.The genetic architecture of type 2 diabetes [J]. Nature, 2016, 536(7614): 41.
26
Xue A,Wu Y,Zhu Z, et al. Genome-wide assocition analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes [J]. Nat commun, 2018, 9(1): 2491.
27
Tanaka D,Nagashima K,Sasaki M, et al. Exome sequencing identifies a new candidate mutation for susceptibility to diabetes in a family with highly aggregated type 2 diabetes [J]. Mol Genet Metab, 2013, 109(1): 112-117.
28
何欢, 罗志军. 磷脂酰乙醇胺结合蛋白4结构和功能特证性研究以及与2型糖尿病的关联[D]. 南昌大学, 2016.
29
王帅, 金磊, 海春旭, 等. PI3K/AKt信号通路在胰岛素抵抗中作用的研究进展. 毒理学杂志, 2015, 29(4): 313-316.
30
张雅中, 房辉, 田金莉, 等. 2型糖尿病家系胰岛素抵抗与血清抵抗素水平的相关性研究[J]. 中国现代医学杂志, 2012, 22(1): 42-44.
31
黄融, 胡耀敏, 陈雅文, 等. 2型糖尿病家系一级亲属的胰岛素抵抗和胰岛β细胞功能研究[J]. 上海交通大学学报, 2011, 31(7): 937-941.
32
Ung C,Sanchez AV,Shen L, et al.Whole exome sequencing identification of novel candidate genes in patients with proliferative diabetic retinopathy [J]. Vision res, 2017, 139.
33
杨光燃, 阿叁, 冯伟, 等.糖尿病增殖型视网膜病变外显子组测序研究[J]. 首都医科大学学报, 2011, 32(5): 598-601.
34
王玉华, 蔡春友, 李卫东, 等. 全外显子组测序发现FUT6基因在1例糖尿病肾病中的终止突变[J]. 天津医科大学学报, 2015, 21(1): 18-21.
35
王玉华. FUT6在TGF-β诱导的肾小管上皮-间充质转化中的作用研究[D]. 天津医科大学, 2015.
36
Strutz FM.EMT and proteinuria as progression factors [J]. Kidney Int, 2009, 75(5): 475-481.
[1] 曹雯佳, 刘学兵, 罗安果, 钟释敏, 邓岚, 王玉琳, 李赵欢. 超声矢量血流成像对2型糖尿病患者颈动脉壁剪切应力的研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 709-717.
[2] 铁晓玲, 刘毅, 杨颖, 车凤玉. Rubinstein-Taybi综合征先证者3例并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 452-459.
[3] 张学. 说基因话疾病[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 366-.
[4] 孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[5] 李猛, 姜腊, 董磊, 吴情, 贾犇黎. 腹腔镜胃袖状切除术治疗肥胖合并2型糖尿病及脂肪胰的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 554-557.
[6] 刘文竹, 唐窈, 刘付臣. 诱导多潜能干细胞在神经肌肉疾病研究中的应用进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 367-373.
[7] 陆文琪, 赵艳茹, 李焕娣, 樊欣娜, 王佳, 李萍. 2型糖尿病患者血清SMAD2和SOX6表达及其与蛋白尿的关系[J/OL]. 中华肾病研究电子杂志, 2024, 13(03): 145-151.
[8] 王璇, 娜扎开提·尼加提, 雒洋洋, 蒋升. 皮肤晚期糖基化终末产物浓度与2型糖尿病微血管并发症的相关性[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 447-454.
[9] 王星, 陈园, 热孜万古丽·乌斯曼, 郭艳英. T2DM、Obesity、NASH、PCOS共同致病因素相关的分子机制[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 481-490.
[10] 李玺, 蔡芸莹, 张永红, 苏恒. 假性软骨发育不全合并1型糖尿病一例[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 518-520.
[11] 孙秀芹, 高美娟, 张琼阁, 吕凯敏, 王宏宇. 京西地区无心血管病史2型糖尿病中老年人群患心血管疾病的危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(03): 245-252.
[12] 张冬雷, 刘晓燕, 吴三云, 周怡, 张岘. 一例遗传性凝血因子Ⅻ缺乏症家系报道及中国人群凝血因子Ⅻ缺乏症分析[J/OL]. 中华临床实验室管理电子杂志, 2024, 12(03): 162-169.
[13] 张滕, 陶艳玲. Shwachman-Diamond综合征继发骨髓增生异常综合征一例及文献复习[J/OL]. 中华诊断学电子杂志, 2024, 12(03): 178-182.
[14] 吴晓明, 翟仰魁, 王娟, 张硕, 许杰, 潘从清. 男性2 型糖尿病患者空腹C 肽和定量胰岛素敏感性检测指数与血浆致动脉粥样硬化指数的相关性[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 288-294.
[15] 张梅, 陈卉, 李转霞, 王瑞, 李林娟. Metrnl和NLRP3炎症小体:糖尿病肾病的潜在诊断标志物[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 193-199.
阅读次数
全文


摘要